Global Samd Software As A Medical Device Market Share 2024, Forecast To 2033
8 Mar, 2024
The software as a medical device (SaMD) market has experienced exponential growth, with its size expected to rise from $24.29 billion in 2023 to $30.4 billion in 2024, demonstrating a compound annual growth rate (CAGR) of 25.2%. This growth is attributed to factors such as globalization, increasing complexity of challenges, and shared research and development costs. Looking forward, the market is poised for further exponential growth, projected to reach $74.86 billion in 2028, with a CAGR of 25.3%. Anticipated drivers of this growth include regulatory changes, concerns regarding cybersecurity, and the integration of artificial intelligence and data analytics. Major trends in the forecast period include ecosystem partnerships, rapid technological obsolescence, and the imperative for innovation to meet evolving healthcare needs.
Global SaMD Software As A Medical Device Market Key Driver
The software as a medical device (SaMD) market foresees growth with the rising adoption of IoT in healthcare, driven by increasing patient acceptance and utilization of remote patient monitoring technologies. Data from Medicon Publications and the Centers for Disease Control and Prevention highlight the growing trend towards telemedicine and IoT-based healthcare solutions.
Get A Free Sample Of The Global SaMD Software As A Medical Device Market ReportGlobal SaMD Software As A Medical Device Market Segments
The (samd) software as a medical device market covered in this report is segmented –
1) Device Type:Wearable Device, PCs And Laptop, Smartphone And Tablets
2) Deployment Method:Cloud-Based, On-Premise
3) Application:Diagnostic, Clinical Management
By Geography: The countries covered in the (samd) software as a medical device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
North America was the largest region in the software as a medical device (SaMD) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the (samd) software as a medical device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major SaMD Software As A Medical Device Industry Players
Apple Inc.; McKesson Corporation; Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthcare GmbH; GE HealthCare Technologies Inc.; Roche Diagnostics; 3M Health Care; Cerner Corporation; Illumina Inc.; Philips Medical Systems Ltd.; Dexcom Inc.; Sysmex Corporation; Carl Zeiss Meditec AG; Nihon Kohden Corporation; Zhlke Group; Viz ai Inc.; Paragon Biosciences LLC; S3 Connected Health; Arterys Inc.; BrightInsight Inc.; Agfa HealthCare Corp.; iSchemaView Inc.; VitalConnect Inc.; Volpara Health Technologies; Tietronix Software Inc.; Velentium LLC; Greenfinch Technology Ltd.; MaxQ AI Ltd.; IDx Technologies Inc.
Get The Full Global SaMD Software As A Medical Device Market Report
SaMD Software As A Medical Device Market Overview
Software as a medical device (SaMD) refers to software-designed devices intended to be used for medical purposes without needing a physical medical device. It is a term used to classify software applications or programs that have a medical function and are used in diagnosing, treating, or monitoring medical conditions.